A panel of experts convened by the National Institutes of Health today released COVID-19 treatment guidelines for health care providers, which will be updated as new data become available.

Based on preliminary and published data, the guidelines include recommendations for two categories of therapy currently under investigation: antivirals, such as chloroquine and remdesivir; and host modifiers/immune-based therapies, such as convalescent plasma.

Each recommendation includes a rating for strength of recommendation and for quality of evidence supporting the recommendation. They also include guidance on caring for critically ill patients and using concomitant medications for treatment, such as statins and corticosteroids

Related News Articles

Headline
The Centers for Medicare & Medicaid Services this week released updated fact sheets for hospitals and other types of Medicare and Medicaid providers…
Headline
Health care providers who received Provider Relief Fund and/or American Rescue Plan Rural payments exceeding $10,000 total between July 1 and Dec. 31, 2021,…
Headline
The House last night voted 220-210 to pass legislation (H.R.382) that would immediately terminate the COVID-19 public health emergency, and 227-203 to pass…
Headline
As the Congressional Telehealth Caucus considers updates to legislation that would permanently remove all geographic restrictions on Medicare telehealth…
Headline
The Biden Administration plans to end on May 11 the COVID-19 national and public health emergencies declared in 2020, according to a policy statement …
Headline
The Centers for Medicare & Medicaid Services Friday released additional guidance on changes to the Medicaid continuous enrollment requirement under…